Alert: Major Price Decline (12/2/19)-Lexicon Pharmaceuticals Inc (NASDAQ: LXRX).


Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) stock suffered a major decline of -10.5% on 12/2/19. The shares closed at $3.16. Moreover, exceptionally high trading volume at 214% of normal accompanied the decline. The stock has declined -22.4% during the last week and has been extremely weak relative to the market over the last nine months.


Current PriceTarget Research Rating

LXRX’s future returns on capital are forecasted to fall short of the cost of capital. Accordingly, the company is expected to be a major Value Eraser.

LXRX is currently unrated.

Rating Review

The stock is currently unrated.

About John Lafferty 79039 Articles
During his career, John has developed valuation and stock rating methodologies, managed institutional portfolios and mutual funds, and provided equity research to institutional investors on thousands of companies. He has been Director of Research at PTR since its inception in 2004.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.